Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Single nucleotide polymorphisms of the aromatase gene (CYP19A1), HER2/neu status, and prognosis in breast cancer patients.

Breast cancer research and treatment - 1 Nov 2008

Fasching Peter Andreas, Loehberg Christian R, Strissel Pamela L, Lux Michael P, Bani Mayada R, Schrauder Michael, Geiler Sonja, Ringleff Kerstin, Oeser Sonja, Weihbrecht Sebastian, Schulz-Wendtland Rüdiger, Hartmann Arndt, Beckmann Matthias W, Strick Reiner

Abstract excerpt

PURPOSE: Estrogen exposure is involved in both breast cancer susceptibility and the prognosis in patients with breast cancer. Aromatase is involved in the production of estrogens, and altered expression of it might be associated with the prognosis. The aim of this study was to examine the effect of single nucleotide polymorphisms (SNPs) in the aromatase gene, CYP19A1, on the prognosis, and in relation to tumor...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to 3' Untranslated Regions
Share to Aromatase

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Ductal, Breast

Share to Carcinoma, Lobular

Share to DNA, Neoplasm

Share to Neoplasm Staging

Share to Receptor, ErbB-2

Share to Survival Rate

Source

Identifiers

PMID: 18049890
DOI: 10.1007/s10549-007-9822-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Single nucleotide polymorphisms of the aromatase gene (CYP19A1), HER2/neu status, and prognosis in breast cancer patients.PMID 18049890Read ↗

Elevated Aromatase (CYP19A1) Expression Is Associated with a Poor Survival of Patients with Estrogen Receptor Positive Breast Cancer.Semantic proximity Read ↗

Genetic variation in the androgen estrogen conversion pathway in relation to breast cancer prognosticators.Semantic proximity Read ↗

Research on aromatase gene (CYP19A1) polymorphisms as a predictor of endocrine therapy effectiveness in breast cancer.Semantic proximity Read ↗

Genetic polymorphisms of the CYP19A1 gene and breast cancer survival.Semantic proximity Read ↗

Influence of CYP19A1 polymorphisms on the treatment of breast cancer with aromatase inhibitors: a systematic review and meta-analysis.Semantic proximity Read ↗

The impact of CYP19A1 variants and haplotypes on breast cancer risk, clinicopathological features and prognosis.Semantic proximity Read ↗

Associations between aromatase CYP19 rs10046 polymorphism and breast cancer risk: from a case-control to a meta-analysis of 20,098 subjects.Semantic proximity Read ↗

The CYP19 RS4646 polymorphism IS related to the prognosis of stage I-II and operable stage III breast cancer.Semantic proximity Read ↗

Analysis of the rs10046 polymorphism of aromatase (CYP19) in premenopausal onset of human breast cancer.Semantic proximity Read ↗

Polymorphisms of ESR1, UGT1A1, HCN1, MAP3K1 and CYP2B6 are associated with the prognosis of hormone receptor-positive early breast cancer.Semantic proximity Read ↗

Significance of the Estrogen Hormone and Single Nucleotide Polymorphisms in the Progression of Breast Cancer among Female.Semantic proximity Read ↗

The implications of genetic variation for the pharmacokinetics and pharmacodynamics of aromatase inhibitors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.